NEW YORK (GenomeWeb) – A kit for detection of dengue virus manufactured by California-based Globavir Biosciences has been approved by the ministry of health and welfare in India, and the company has partnered with Suyog Diagnostics to distribute the test there.

Globavir said its test, called the PanGlob Dengue rRT-PCR kit, has higher sensitivity than other commercially available tests, allowing for detection of the virus up to five days after initial infection, when viral load is substantially decreased. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.